A study in 112 diabetic patients without HF treated with either ipragliflozin, luseogliflozin, or dapagliflozin demonstrated that patients’ hand grip strength increased after treatment with all three SGLT2 inhibitors [177]. This evidence concerns the gene SLC5A2 and hydrops fetalis.